Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series
Background: Patients with severe asthma are often dependent on oral corticosteroids (OCS) and have frequent exacerbations. This article aims to report very long-term data of patients with severe eosinophilic asthma assessing asthma control, lung function, inhaled corticosteroid (ICS) dose reduction,...
Saved in:
Main Authors: | Carlo Lombardi (Author), Francesco Menzella (Author), Alvise Berti (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical usefulness of mepolizumab in severe eosinophilic asthma
by: Menzella F, et al.
Published: (2016) -
Long-term effects of mepolizumab in patients with severe eosinophilic asthma: a 6-year real-life experience
by: Anna Agnese Stanziola, et al.
Published: (2024) -
Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
by: Manuel David Gil-Sierra, et al.
Published: (2019) -
Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice
by: Olalla Montero-Pérez, et al.
Published: (2019) -
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
by: Pelaia C, et al.
Published: (2017)